AryoGen Pharmed Co.
12 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| rFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic Study (NCT06137092) | AryoGen Pharmed Co. | 2023-07-22 |
| VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation (NCT07273760) | AryoGen Pharmed Co. | 2023-07-16 |
| Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibitors (NCT04789954) | AryoGen Pharmed Co. | 2020-12-29 |
| Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors (NCT03935334) | AryoGen Pharmed Co. | 2018-07-23 |
Track AryoGen Pharmed Co. automatically
Every clearance here is in the API, with alerts when new ones post.